ARCHIVES

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

This article is from The Cancer Letter archive.

Vol. 20 No. 11 | March 18, 1994

Download PDF Visit The Full Archive

Related Articles

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

Litton Awarded $342,618 For Frederick Fee

February 21, 1975

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

October 17, 1980

NCI Advisory Group, Other Cancer Meetings for October, November

September 24, 1976

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008